These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 23087433

  • 1. Localized mucosal response to intranasal live attenuated influenza vaccine in adults.
    Barría MI, Garrido JL, Stein C, Scher E, Ge Y, Engel SM, Kraus TA, Banach D, Moran TM.
    J Infect Dis; 2013 Jan 01; 207(1):115-24. PubMed ID: 23087433
    [Abstract] [Full Text] [Related]

  • 2. Pre-existing influenza-specific nasal IgA or nasal viral infection does not affect live attenuated influenza vaccine immunogenicity in children.
    Cole ME, Kundu R, Abdulla AF, Andrews N, Hoschler K, Southern J, Jackson D, Miller E, Zambon M, Turner PJ, Tregoning JS.
    Clin Exp Immunol; 2021 Apr 01; 204(1):125-133. PubMed ID: 33314126
    [Abstract] [Full Text] [Related]

  • 3. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR, Vincent AL, Brockmeier SL, Gauger PC, Pena L, Santos J, Braucher DR, Perez DR, Loving CL.
    Clin Vaccine Immunol; 2015 Oct 01; 22(10):1109-20. PubMed ID: 26291090
    [Abstract] [Full Text] [Related]

  • 4. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
    Rudenko L, Kiseleva I, Krutikova E, Stepanova E, Rekstin A, Donina S, Pisareva M, Grigorieva E, Kryshen K, Muzhikyan A, Makarova M, Sparrow EG, Torelli G, Kieny MP.
    PLoS One; 2018 Oct 01; 13(12):e0208028. PubMed ID: 30507951
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S, Ainai A, Suzuki T, Kurata T, Hasegawa H.
    Jpn J Infect Dis; 2016 Oct 01; 69(3):165-79. PubMed ID: 27212584
    [Abstract] [Full Text] [Related]

  • 7. Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
    Manenti A, Tete SM, Mohn KG, Jul-Larsen Å, Gianchecchi E, Montomoli E, Brokstad KA, Cox RJ.
    Vaccine; 2017 Jan 03; 35(1):191-198. PubMed ID: 27789145
    [Abstract] [Full Text] [Related]

  • 8. Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
    Mohn KG, Brokstad KA, Islam S, Oftung F, Tøndel C, Aarstad HJ, Cox RJ.
    J Infect Dis; 2020 Apr 07; 221(9):1528-1537. PubMed ID: 32255493
    [Abstract] [Full Text] [Related]

  • 9. T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.
    Li J, Arévalo MT, Chen Y, Chen S, Zeng M.
    Int J Infect Dis; 2014 Oct 07; 27():37-43. PubMed ID: 25172265
    [Abstract] [Full Text] [Related]

  • 10. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z, Cardenas Garcia S, Liu J, Santos J, Carnaccini S, Geiger G, Ferreri L, Rajao D, Perez DR.
    J Virol; 2018 Nov 01; 92(21):. PubMed ID: 30135124
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.
    Lewis KDC, Ortiz JR, Rahman MZ, Levine MZ, Rudenko L, Wright PF, Katz JM, Dally L, Rahman M, Isakova-Sivak I, Ilyushina NA, Matyushenko V, Fry AM, Lindstrom SE, Bresee JS, Brooks WA, Neuzil KM.
    Clin Infect Dis; 2019 Aug 16; 69(5):777-785. PubMed ID: 30481272
    [Abstract] [Full Text] [Related]

  • 12. Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response.
    Aljurayyan A, Puksuriwong S, Ahmed M, Sharma R, Krishnan M, Sood S, Davies K, Rajashekar D, Leong S, McNamara PS, Gordon S, Zhang Q.
    J Virol; 2018 Jun 01; 92(11):. PubMed ID: 29563292
    [Abstract] [Full Text] [Related]

  • 13. Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination.
    Levine MZ, Martin JM, Gross FL, Jefferson S, Cole KS, Archibald CA, Nowalk MP, Susick M, Moehling K, Spencer S, Chung JR, Flannery B, Zimmerman RK.
    Clin Vaccine Immunol; 2016 Oct 01; 23(10):831-839. PubMed ID: 27558294
    [Abstract] [Full Text] [Related]

  • 14. Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.
    Stephenson I, Zambon MC, Rudin A, Colegate A, Podda A, Bugarini R, Del Giudice G, Minutello A, Bonnington S, Holmgren J, Mills KH, Nicholson KG.
    J Virol; 2006 May 01; 80(10):4962-70. PubMed ID: 16641287
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Block SL, Yi T, Sheldon E, Dubovsky F, Falloon J.
    Vaccine; 2011 Nov 21; 29(50):9391-7. PubMed ID: 21983154
    [Abstract] [Full Text] [Related]

  • 16. [Local antibody immune responses in influenza patients and persons vaccinated with seasonal, pre-pandemic, and pandemic live attenuated influenza vaccines].
    Donina SA, Petukhova GD, Koren'kov DA, Grigor'eva EP, Kuznetsova SA, Losev IV, Rudenko LG, Naĭkhin AN.
    Vopr Virusol; 2013 Nov 21; 58(3):37-42. PubMed ID: 24006632
    [Abstract] [Full Text] [Related]

  • 17. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
    Liu WC, Nachbagauer R, Stadlbauer D, Solórzano A, Berlanda-Scorza F, García-Sastre A, Palese P, Krammer F, Albrecht RA.
    Front Immunol; 2019 Nov 21; 10():756. PubMed ID: 31105689
    [Abstract] [Full Text] [Related]

  • 18. Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
    Ainai A, van Riet E, Ito R, Ikeda K, Senchi K, Suzuki T, Tamura SI, Asanuma H, Odagiri T, Tashiro M, Kurata T, Multihartina P, Setiawaty V, Pangesti KNA, Hasegawa H.
    Microbiol Immunol; 2020 Apr 21; 64(4):313-325. PubMed ID: 31957054
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group.
    Pediatr Infect Dis J; 2006 Oct 21; 25(10):860-9. PubMed ID: 17006278
    [Abstract] [Full Text] [Related]

  • 20. An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.
    Lambkin-Williams R, Gelder C, Broughton R, Mallett CP, Gilbert AS, Mann A, He D, Oxford JS, Burt D.
    PLoS One; 2016 Oct 21; 11(12):e0163089. PubMed ID: 28005959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.